Home › Funds › MAK CAPITAL ONE LLC › ANNX
MAK CAPITAL ONE LLC position in ANNX
ANNEXON INC · Health Care
MAK CAPITAL ONE LLC reported holding 5,862,180 shares of ANNX (ANNEXON INC) in its Q2 2026 13F filing — a position valued at US$33.5M, representing 4.69% of its reported portfolio and ranking #10 among its reported holdings. MAK CAPITAL ONE LLC has disclosed ANNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MAK CAPITAL ONE LLC's ANNX position evolved
MAK CAPITAL ONE LLC first disclosed a stake in ANNX in Q4 2025 at 2,958,527 shares (US$14.9M). The position peaked in Q2 2026 at 5,862,180 shares, worth US$33.5M. Across 3 filings, MAK CAPITAL ONE LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,862,180 shares valued at US$33.5M — an increase of 1,138,137 shares quarter over quarter.. Notable position changes include a 60% increase in Q1 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.96M | $14.85M | New |
| Q1 2026 | 4.72M | $26.17M | Add |
| Q2 2026 | 5.86M | $33.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANNX and 13F data
ANNX (ANNEXON INC) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), BVF INC/IL (US$49.7M), Siren, L.L.C. (US$25.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- BVF INC/IL 8.70M sh · $49.67M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- Bellevue Group AG 4.10M sh · $23.41M · Q2 2026
- MPM BioImpact LLC 3.54M sh · $20.24M · Q2 2026
- GREAT POINT PARTNERS LLC 3.50M sh · $19.98M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Opaleye Management Inc. 1.71M sh · $9.79M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on MAK CAPITAL ONE LLC
FAQ
How long has MAK CAPITAL ONE LLC held ANNX?
MAK CAPITAL ONE LLC has disclosed ANNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is MAK CAPITAL ONE LLC's current position in ANNX?
As of Q2 2026, MAK CAPITAL ONE LLC holds 5.86M shares of ANNX (ANNEXON INC), valued at $33.47M, representing 4.69% of its reported portfolio and ranking #10.
Has MAK CAPITAL ONE LLC been buying or selling ANNX?
In the latest 13F filing (Q2 2026), MAK CAPITAL ONE LLC increased its position in ANNX. The position peaked in Q2 2026 at 5.86M shares.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, Siren, L.L.C., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.